AI Verdict
ZTS has stronger fundamentals based on our AI analysis.
ABBV vs ZTS Fundamental Comparison
| Metric | ABBV | ZTS |
|---|---|---|
| Revenue | $61.2B | $9.5B |
| Net Income | $4.2B | $2.7B |
| Net Margin | 6.9% | 28.2% |
| ROE | N/A | 80.2% |
| ROA | 3.2% | 17.3% |
| Current Ratio | 0.67x | 3.03x |
| Debt/Equity | N/A | 2.71x |
| EPS | $2.36 | $6.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs ZTS: Frequently Asked Questions
Is ABBV or ZTS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ZTS has stronger fundamentals. ABBV is rated HOLD (70% confidence) while ZTS is rated BUY (78% confidence). This is not investment advice.
How does ABBV compare to ZTS fundamentally?
AbbVie Inc. has ROE of N/A vs Zoetis Inc.'s 80.2%. Net margins are 6.9% vs 28.2% respectively.
Which stock pays higher dividends, ABBV or ZTS?
ABBV has a dividend yield of N/A or no dividend while ZTS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or ZTS for long term?
For long-term investing, consider that ABBV has HOLD rating with 70% confidence, while ZTS has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs ZTS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs ZTS, the AI consensus favors ZTS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.